Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
| Market Capitalization | $14.0192 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.018 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.02 |
| EBITDA | -3,136.448 |
| Profit Margin | 0 |
| Operating Margin TTM | -21.3208 |
| Return on Assets TTM | -0.3571 |
| Return on Equity TTM | -0.6524 |
| Revenue TTM | 149.232 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2014-06-30 | 0.076 | 0 | 0.076 | 137.545 |
| 2015-06-30 | 1 | 0 | 0 | 178.702 |
| 2016-06-30 | 186.42 | 27.401 | 159.014 | 508.933 |
| 2017-06-30 | 106.73 | 25.157 | 81.568 | 1,161.627 |
| 2018-06-30 | 6.784 | 56.894 | 6.784 | 3,307.573 |
| 2019-06-30 | 508.758 | 61.086 | 508.758 | 2,700.175 |
| 2020-06-30 | 907.58 | 907.58 | 3,068.476 | |
| 2021-06-30 | 573.119 | 573.119 | 3,038.463 | |
| 2022-06-30 | 879.776 | 879.776 | 3,853.311 | |
| 2023-06-30 | 595.078 | 595.078 | 3,777.072 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2014-06-30 | 51 | 291 | 1 | 1,265 | ||
| 2015-06-30 | 208.81 | 435.36 | 1,549.908 | |||
| 2016-06-30 | 101.646 | 856.349 | 383 | 1,779.147 | ||
| 2017-06-30 | 8,792.879 | 9,445.428 | 373.935 | 0 | 150 | 11,956.499 |
| 2018-06-30 | 6,706.552 | 7,666.894 | 759.587 | 0 | 150 | 11,768.501 |
| 2019-06-30 | 4,499.364 | 5,563.072 | 613.611 | 0 | 150 | 11,804.199 |
| 2020-06-30 | 5,521.868 | 6,569.596 | 567.288 | 11.663 | 150 | 14,535.664 |
| 2021-06-30 | 3,933.195 | 5,000.751 | 754.573 | 0 | 150 | 15,062.071 |
| 2022-06-30 | 6,341.881 | 7,303.155 | 1,034.682 | 0 | 0 | 19,545.553 |
| 2023-06-30 | 2,990.527 | 3,835.233 | 613.884 | 0 | 0 | 19,545.553 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2014-06-30 | -87.306 | -47.567 | 8.406 | |||
| 2015-06-30 | -98.261 | -126.95 | 157.55 | |||
| 2016-06-30 | -322.518 | -419.345 | -107.165 | |||
| 2017-06-30 | -1,054.902 | -729.15 | 2,758.68 | 2,860.324 | ||
| 2018-06-30 | -2,833.05 | -2,373.454 | 3,846.228 | 2,860.324 | 6,706.552 | |
| 2019-06-30 | -1,919.723 | -2,201.479 | -2,207.188 | 6,706.552 | 4,499.364 | |
| 2020-06-30 | -1,705.302 | -1,644.691 | 1,022.504 | 4,499.364 | 5,521.868 | |
| 2021-06-30 | -2,327.184 | -1,825.522 | -1,588.673 | 5,521.868 | 3,933.195 | |
| 2022-06-30 | -2,914.193 | 43.515 | 2,408.686 | 3,933.195 | 6,341.881 | |
| 2023-06-30 | -3,095.782 | -3,276.35 | -3,351.354 | 6,341.881 | 2,990.527 |